Background: In recent years, mobile health (mHealth)–related apps have been developed
to help manage chronic diseases. Apps may allow patients with a chronic disease …

Introduction There are no data on the association of type of pneumonia and long-term mortality
by the type of pneumonia (COVID-19 or community-acquired pneumonia [CAP]) on long-…

Introduction This manuscript analyzes the exacerbations recorded by the Prevexair application
through the daily analysis of symptoms in high-risk patients with COPD and explores its …

PURPOSE: CS use is associated with higher risk of infection. However, there is limited data
available regarding the impact of outpatient CS on sepsis-related mortality. Therefore, our …

Introduction There are different therapeutic approaches to support smoking cessation and
long-term smoking abstinence that have shown to be cost-effective. Objective:To analyse the …

Introduction: Chronic obstructive pulmonary disease (COPD) may have serious manifestation
and an impact on the functional situation of the severe patients. Objective: to characterize …

Introduction: The treatment of chronic obstructive pulmonary disease exacerbations (AECOPD)
improves the outcomes; however, patients with COPD often fail to seek therapy. Most …

Introduction: Over the last few years, health-related applications have been developed to
assist chronic patients follow a healthier life. However, the compliance of the patients with a …

Background COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2)
and causes substantial morbidity and mortality. At the time this clinical trial was planned, …

… Rosa Malo de Molina has received speaker's fees from Boehringer Ingelheim, Pfizer,
AstraZeneca, Chiesi, GlaxoSmithKline, Menarini, and Novartis. Sagrario Mayoralas-Alises has …